Darunavir: Difference between revisions

'''Darunavir''' ('''DRV'''), sold under the brand name '''Prezista''' among others, is an [[antiretroviral medication]] used to treat and prevent [[HIV/AIDS]].<ref name=AHFS2016/> It is generally recommended for use with other antiretrovirals.<ref name=AHFS2016/><ref name="Prezista FDA label">{{cite web | title=Prezista- darunavir tablet, film coated Prezista- darunavir suspension | website=DailyMed | date=6 June 2019 | url=https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=814301f9-c990-46a5-b481-2879a521a16f | access-date=21 April 2020}}</ref> It is often used with low doses of [[ritonavir]] or [[cobicistat]] to increase darunavir levels.<ref name=AHFS2016/> It may be used for prevention after a [[needlestick injury]] or other potential exposure.<ref name=AHFS2016/> It is taken [[Oral administration|by mouth]] once to twice a day.<ref name=AHFS2016>{{cite web|title=Darunavir|url=https://www.drugs.com/monograph/darunavir.html|publisher=The American Society of Health-System Pharmacists|accessdateaccess-date=28 November 2016|url-status=live|archive-url=https://web.archive.org/web/20161110112612/https://www.drugs.com/monograph/darunavir.html|archive-date=10 November 2016}}</ref>